Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is ...

TIME ELAPSED: 6–11 DAYS The Virus Takes Countermeasures SARS-CoV-2 uses several tactics to thwart the immune system’s response. Tactic 1: The virus spike may camouflage itself with sugar ...

What actually happened was that SARS-CoV ... the spike protein (which helps penetrate human cells) but not in the rest of the virus. This pattern is clearly found in both BA.1 and BA.2 versions ...

People with PVS who had never had COVID also had lower levels of antibodies against the SARS-CoV-2 spike protein, likely because they tended to have fewer vaccine doses, according to the release.

Wuhan: Researchers from China have identified a new bat coronavirus named HKU5-CoV-2, which can potentially infect humans. This virus targets the same receptor as SARS-CoV-2, the virus linked to ...

(Reuters) Chinese researchers have identified a newly discovered bat coronavirus that uses the same cell-surface protein, ACE2, to enter human cells as SARS-CoV-2, the virus responsible for COVID-19.

New COVID Variant: In 2019, the world saw the emergence of the deadliest virus outbreak SARS-CoV-2, which caused COVID ... mutations happening in the spike protein of the parent COVID strain.